English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduWilliam Borden, is a professor of medicine and health policy at the GW School of Medicine and Health Sciences. He specializes in preventive cardiology, the treatment of complex cholesterol disorders, and diagnosing and treating general cardiovascular diseases. Brian Choi, is…
Tag: Cardiovacular Disease
New Technology Promises to Revolutionize Valvular Heart Disease Care
Experts advance models for speedy adoption for better diagnosis and therapy in The Lancet.
Johns Hopkins Bloomberg School Researchers Develop Universal Risk Predictor for Cardiovascular Disease
Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a single “universal risk prediction model” for cardiovascular disease that, in initial tests, works well for patients who already have cardiovascular disease as well as patients who do not but who may be at risk for developing it.
Social determinants of health contribute to higher CVD mortality rates in Black persons
A study of more than 50,000 US adults suggests that social determinants of health are a major contributing factor to higher mortality rates from cardiovascular disease (CVD) in Black individuals compared to Whites. The findings are published in Annals of Internal Medicine.
New study finds U.S. military veterans living in discriminatory ‘redlined’ areas suffered higher rates of cardiovascular disease
U.S. military veterans who lived in what were once known as “redlined” areas had a higher risk for heart attacks and other cardiovascular issues, according to a new study by researchers at Case Western Reserve University, University Hospitals and the Cleveland VA Medical Center.
CTO Plus 2023 Will Feature Latest Research and Techniques for Chronic Total Occlusions and Complex PCI
CTO Plus 2023 will feature the latest research and techniques for chronic total occlusions (CTO) and complex percutaneous coronary interventions (PCI). The annual conference, organized by the Cardiovascular Research Foundation (CRF), will take place February 23-24 at the New York Marriott Marquis in New York, NY.
In Patients with Fatty Liver, Bariatric Surgery Decreases Risk of Progression of Liver Disease, Serious Heart Complications
A Cleveland Clinic study shows that patients with obesity and advanced fatty liver disease who had bariatric weight loss surgery significantly lowered their future risk of liver disease complications and serious cardiovascular disease compared with patients who did not have surgery.
Genetic evidence suggests men can develop PCOS-like condition
New genetic research suggests men can develop characteristics of polycystic ovary syndrome (PCOS)—a common metabolic and reproductive disorder that affects women. The study was presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
American Heart Month: FSU experts available to comment on heart disease topics
By: Kelsey Klopfenstein | Published: February 3, 2021 | 1:14 pm | SHARE: Heart disease is the leading cause of death in the United States. Someone has a heart attack every 39 seconds, and cardiovascular disease claims more lives each year than all forms of cancer combined, according to the American Heart Association’s 2021 Heart Disease and Stroke Statistics Update.
Stem Cell Study Illuminates the Cause of a Devastating Inherited Heart Disorder
Stem cell study findings show that LMNA gene mutations can disrupt the “identity” of heart muscle cells
Study: National calorie menu labeling law will add years of healthy living, save billions
The national law requiring calorie labeling on menus at large chain restaurants is estimated to prevent tens of thousands of new heart disease and type 2 diabetes cases—and save thousands of lives—in just five years, according to a new study that estimates the law’s impact.
Two types of diabetes drugs similarly effective in reducing heart and kidney disease
Two newer types of medications commonly used to treat type 2 diabetes are similar in their ability to reduce major heart complications, including heart attack, stroke and death from cardiovascular disease, according to research accepted for presentation at ENDO 2020, the Endocrine Society’s annual meeting, and publication in a special supplemental section of the Journal of the Endocrine Society.